JPMorgan Chase & Co’s Immuneering IMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.65K | Hold |
1,974
| – | – | ﹤0.01% | 5503 |
|
|
2025
Q1 | $3K | Hold |
1,974
| – | – | ﹤0.01% | 5624 |
|
|
2024
Q4 | $4.34K | Sell |
1,974
-450
| -19% | -$990 | ﹤0.01% | 5489 |
|
|
2024
Q3 | $6.04K | Buy |
2,424
+450
| +23% | +$1.12K | ﹤0.01% | 5398 |
|
|
2024
Q2 | $2.53K | Sell |
1,974
-7,315
| -79% | -$9.36K | ﹤0.01% | 5478 |
|
|
2024
Q1 | $26.8K | Sell |
9,289
-6,785
| -42% | -$19.6K | ﹤0.01% | 5162 |
|
|
2023
Q4 | $118K | Sell |
16,074
-4,285
| -21% | -$31.5K | ﹤0.01% | 4693 |
|
|
2023
Q3 | $156K | Buy |
20,359
+3,577
| +21% | +$27.5K | ﹤0.01% | 4369 |
|
|
2023
Q2 | $170K | Buy |
16,782
+15,752
| +1,529% | +$160K | ﹤0.01% | 4364 |
|
|
2023
Q1 | $10K | Buy |
1,030
+70
| +7% | +$680 | ﹤0.01% | 5271 |
|
|
2022
Q4 | $5K | Sell |
960
-183
| -16% | -$953 | ﹤0.01% | 5219 |
|
|
2022
Q3 | $16K | Buy |
1,143
+10
| +0.9% | +$140 | ﹤0.01% | 4975 |
|
|
2022
Q2 | $6K | Sell |
1,133
-10,836
| -91% | -$57.4K | ﹤0.01% | 5264 |
|
|
2022
Q1 | $78K | Buy |
11,969
+6,515
| +119% | +$42.5K | ﹤0.01% | 4842 |
|
|
2021
Q4 | $88K | Buy |
5,454
+2,287
| +72% | +$36.9K | ﹤0.01% | 4881 |
|
|
2021
Q3 | $84K | Buy |
+3,167
| New | +$84K | ﹤0.01% | 4791 |
|